NCT00002766 - Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

LeukemiaLymphoma

Interventions

BIOLOGICAL

dactinomycin

BIOLOGICAL

sargramostim

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

mercaptopurine

DRUG

methotrexate

DRUG

mitoxantrone hydrochloride

DRUG

pegaspargase

DRUG

prednisone

DRUG

vincristine sulfate

RADIATION

radiation therapy

Trial Locations (7)

10021

Memorial Sloan-Kettering Cancer Center, New York

10595

New York Medical College, Valhalla

27710

Duke Comprehensive Cancer Center, Durham

30322

Winship Cancer Institute of Emory University, Atlanta

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

90095-1678

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

94305-5750

Stanford Cancer Center at Stanford University Medical Center, Stanford

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER